Impact of IFN‐Free and IFN‐Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan‐DC, and Activated T Lymphocyte Dynamics during HCV Infection
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2020 (1) , 2781350
Abstract
Chronic hepatitis C virus infection leads to the activation of innate immunity, a key component in HCV fibrosis. In the past, the use of IFN‐based treatment regimens did not permit an adequate evaluation of the impact of HCV clearance on immune cells, because of their antiviral and immunomodulatory properties. The recent development of direct‐acting antiviral (DAA) therapy, which is associated with high rates of sustained virological response, enables a more accurate analysis of the immunological modifications following HCV eradication. We studied the dynamics of blood myeloid dendritic cells, monocytes, slan‐DCs, and T lymphocytes during IFN‐free and IFN‐based regimens in hepatitis C virus infection.Keywords
This publication has 39 references indexed in Scilit:
- IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and DiseasePLOS Pathogens, 2013
- Failure of innate and adaptive immune responses in controlling hepatitis C virus infectionFEMS Microbiology Reviews, 2012
- Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A ProteaseAntimicrobial Agents and Chemotherapy, 2010
- Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 ReceptorsImmunity, 2010
- High Levels of Chronic Immune Activation in the T-Cell Compartments of Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus Type 1 and on Highly Active Antiretroviral Therapy Are Reverted by Alpha Interferon and Ribavirin TreatmentJournal of Virology, 2009
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2009
- Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)Antimicrobial Agents and Chemotherapy, 2008
- Viral and Host Factors Induce Macrophage Activation and Loss of Toll-Like Receptor Tolerance in Chronic HCV InfectionGastroenterology, 2007
- Treating viral hepatitis C: efficacy, side effects, and complicationsGut, 2006
- Impact of Alpha Interferon and Ribavirin on the Function of Maturing Dendritic CellsAntimicrobial Agents and Chemotherapy, 2004